Jury Awards $334 Million in Damages for Complete Genomics in Patent Case Against Illumina
Quinn Emanuel obtained a sweeping victory on behalf of client Complete Genomics, Inc. The suit arose out of allegations that Illumina, a dominant player in the sequencing field, infringed two CGI patents relating to DNA sequencing. CGI was awarded $334 million in damages last Friday after a Delaware federal jury unanimously found that Illumina had willfully infringed CGI’s two asserted patents. In addition, the jury found that CGI invalidated the three sequencing patents that Illumina asserted. Pre-judgment interest, an accounting for damages for 2022, an injunction and the Court enhancing the damages award because of the willfulness finding are all potential further remedies.
The Quinn team consisted of partners David Bilsker, David Perlson, Anne Toker, Brian Cannon, and Andrew Bramhall as well as of counsel and associates, Margaret Shyr, Andrew Naravage, Nate Sun, Andrew Tigchelaar, Cat Williams and Dallas Bullard.